NGL Fine-Chem Ltd.
Snapshot View

1675.25 +11.05 ▲0.7%

08 December 2022, 04:01:00 PM
Volume: 621

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.nglfinechem.com
Market Cap 1,034.97 Cr.
Enterprise Value(EV) 1,049.49 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 35.61 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 47.05 Trailing Twelve Months Ending 2022-09
Industry PE 34.64 Trailing Twelve Months Ending 2022-09
Book Value / Share 334.81 Trailing Twelve Months Ending 2022-09
Price to Book Value 5.00 Calculated using Price: 1,675.25
Dividend Yield 0.10 Period Ending 2022-03
No. of Shares Subscribed 0.62 Cr. 6,178,024 Shares
FaceValue 5
Company Profile
NGL Fine-chem is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health. It caters to various global companies to custom manufacture high quality pharmaceuticals with reliability and flexibility.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.66%
1 Week
-1.22%
1 Month
+8.77%
3 Month
+10.18%
6 Month
-9.51%
1 Year
-35.65%
2 Year
+36.33%
5 Year
+297.78%
10 Year
+11866.07%
4 years 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 21.85 8.72 44.76 27.90
Return on Capital Employed (%) 25.25 11.93 53.53 33.91
Return on Assets (%) 13.49 5.50 31.42 20.61

Balance Sheet View Details >>

Particulars 5 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 92 99 154 203 207
Non Curr. Liab. 12 12 11 8 6
Curr. Liab. 45 43 42 66 61
Minority Int.
Equity & Liab. 149 154 207 277 274
Non Curr. Assets 63 73 83 103 114
Curr. Assets 86 81 125 173 160
Misc. Exp. not W/O
Total Assets 149 154 207 277 274

Profit Loss View Details >>

Particulars 5 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 153 152 258 318 298
Other Income 4 3 8 11 10
Total Income 157 155 266 328 308
Total Expenditure -121 -132 -178 -249 -264
PBIDT 36 23 88 79 44
Interest -3 -3 -2 -2 -3
Depreciation -6 -8 -8 -10 -13
Taxation -7 -4 -21 -17 -7
Exceptional Items
PAT 20 8 57 50 22
Minority Interest
Share Associate
Other Related Items 0 0 0
Consolidated Net Profit 20 8 57 50 22
Adjusted EPS 33 13 92 81 36

Cash Flow View Details >>

Particulars 4 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 9 20 27 14
Cash Fr. Inv. -10 -20 -25 -14
Cash Fr. Finan. -1 -1 -1
Net Change -1 0 2 -1
Cash & Cash Eqvt 1 0 2 1

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 73.81 73.81 73.81 73.81 73.81 73.81 73.81 73.81 73.81
Public 26.19 26.19 26.19 26.19 26.19 26.19 26.19 26.19 26.19
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 25 Nov 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
With reference to the captioned subject data received from the Registrar and Share Transfer Agent we wish to inform you that below mentioned shareholder has reported about loss of Share Certificate.Name of the Shareholder Ramesh MahadevFolio No. R00298Certificate No. 0026853Distinctive No. 2784201 - 2784300No. of Shares 100 Kindly take the same on your record.
Wed, 23 Nov 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
With reference to the captioned subject data received from the Registrar and Share Transfer Agent we wish to inform you that below mentioned shareholder has reported about loss of Share Certificate.Name of the Shareholder PUSHPA SEVENTILAL SHETHSEVENTILAL NAVALCHAND SHETHFolio No. P00514Certificate No. 0059107Distinctive No. 1329581 - 1329680No. of Shares 100Kindly take the same on your record.
Tue, 22 Nov 2022
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 we wish to inform you that the Company participated in the Investors Conference Call on Thursday 17th November 2022 on unaudited financial results for the quarter and half year ended September 30 2022. No unpublished price sensitive information was shared/discussed in the meeting.We enclose herewith the transcript of Concall with the Investors.Kindly take the same on your record.

Technical Scans View Details >>

Thu, 08 Dec 2022
High Delivery Percentage High Delivery Percentage
Closing Above Previous High Closing Above Previous High
Increasing Relative Strength - Sectoral Index Increasing Relative Strength - Sectoral Index
High Increase 1 Month High Increase 1 Month
High Increase 3 Months High Increase 3 Months

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 235,362.76 980.95 -3.6%
Cipla Ltd. 89,585.15 1,110.00 +0.4%
Divi's Laboratories Ltd. 87,333.85 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. 72,223.59 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. 67,735.51 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. 54,831.55 1,620.10 -0.4%
Abbott India Ltd. 43,044.71 20,257.00 +0.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 57.34 980.95 -3.6%
Cipla Ltd. Consolidated 2022-09 34.91 1,110.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-09 29.18 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 23.23 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 80.68 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 68.80 1,620.10 -0.4%
Abbott India Ltd. Standalone 2022-09 48.82 20,257.00 +0.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.43 980.95 -3.6%
Cipla Ltd. Consolidated 2022-09 4.09 1,110.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-09 7.20 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.48 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 11.32 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 9.00 1,620.10 -0.4%
Abbott India Ltd. Standalone 2022-09 15.86 20,257.00 +0.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 980.95 -3.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,110.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,620.10 -0.4%
Abbott India Ltd. Standalone 2022-03 0.00 20,257.00 +0.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 980.95 -3.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,110.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,620.10 -0.4%
Abbott India Ltd. Standalone 2022-03 29.95 20,257.00 +0.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 980.95 -3.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,110.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,620.10 -0.4%
Abbott India Ltd. Standalone 2022-03 29.95 20,257.00 +0.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 980.95 -3.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,110.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,620.10 -0.4%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,257.00 +0.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 980.95 -3.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,110.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,620.10 -0.4%
Abbott India Ltd. Standalone 2022-03 798.70 20,257.00 +0.2%

FAQ's On NGL Fine-Chem Ltd.

What is NGL Fine-Chem share price?

Can I buy NGL Fine-Chem shares now?

What is the Dividend Yield of NGL Fine-Chem?

What is the Market Cap of NGL Fine-Chem?

What are the key metrics to analyse NGL Fine-Chem?

What is the 52 Week High and Low of NGL Fine-Chem?

What is the trend of NGL Fine-Chem share price?